A carregar...
MET Inhibitors for the Treatment of Gastric Cancer: What’s Their Potential?
Gastric cancer remains a disease with a dismal prognosis. Extensive efforts to find targetable disease drivers in gastric cancer were implemented to improve patient outcomes. Beyond anti-HER2 therapy, MET pathway seems to be culprit of cancer invasiveness with MET-overexpressing tumors having poorer...
Na minha lista:
| Publicado no: | J Exp Pharmacol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7547764/ https://ncbi.nlm.nih.gov/pubmed/33116950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S242958 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|